AVR 3.10% $17.20 anteris technologies ltd

Admedus dominating in Europe., page-56

  1. 1,003 Posts.
    lightbulb Created with Sketch. 93
    I know a surgeon in Slovenia (next to Italy) who does TAVR. He travels around a lot for conferences / seminars, says he sees the same people over and over and enjoys the travel because these other surgeons become friends.
    Anyway he was surprised that I had some idea of what he was talking about when describing his job. I told him I invested in a company called AHZ. He hadn't heard of them. This was a year ago.
    About a month ago he had just come back from another conference in the U.S. I asked him again about Admedus. He still hadn't heard of them. From reading HotCopper and hearing all the positives I was very surprised about this. He told me there were lots of companies doing these sorts of patches.

    Now I don't know if he's one of those ignorant cardiac surgeons specialising in TAVR who don't know much about available products or if AHZ is actually not dominating Europe as the title states.

    I sold out soon after our initial chat. It was confirmation along with what I considered ordinary vax results that this company is not as great as many here allude.
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
(20min delay)
Last
$17.20
Change
-0.550(3.10%)
Mkt cap ! $330.6M
Open High Low Value Volume
$17.75 $17.75 $16.88 $199.1K 11.56K

Buyers (Bids)

No. Vol. Price($)
1 500 $17.00
 

Sellers (Offers)

Price($) Vol. No.
$17.24 1000 1
View Market Depth
Last trade - 16.10pm 17/07/2024 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.